Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Oxurion
Oxurion
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Jetrea
Ocriplasmin
2012-10-17
Retinal diseases
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Ocriplasmin
vitrectomy
,
macular degeneration
,
arterial occlusive diseases
,
wet macular degeneration
,
stroke
,
retinal diseases
,
disease progression
,
diabetic retinopathy
,
vitreous detachment
,
thrombosis
,
venous thrombosis
,
macular edema
,
edema
,
ischemic stroke
,
eye diseases
,
papilledema
,
tissue adhesions
,
retinal perforations
Salicylic acid
ischemic stroke
,
stroke
,
ischemia
,
cerebral infarction
Ziv-aflibercept
macular degeneration
Serine
invasive candidiasis
,
candidiasis
,
aspergillosis
,
invasive pulmonary aspergillosis
RO5323441
glioblastoma
,
carcinoma
,
hepatocellular carcinoma
,
liver neoplasms
,
ovarian neoplasms
,
ovarian epithelial carcinoma
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use